• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植前后的骨矿物质密度:长期随访及预测因素

Bone mineral density before and after OLT: long-term follow-up and predictive factors.

作者信息

Guichelaar Maureen M J, Kendall Rebecca, Malinchoc Michael, Hay J Eileen

机构信息

Division of Gastroenterology, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

Liver Transpl. 2006 Sep;12(9):1390-402. doi: 10.1002/lt.20874.

DOI:10.1002/lt.20874
PMID:16933236
Abstract

Fracturing after liver transplantation (OLT) occurs due to the combination of preexisting low bone mineral density (BMD) and early posttransplant bone loss, the risk factors for which are poorly defined. The prevalence and predictive factors for hepatic osteopenia and osteoporosis, posttransplant bone loss, and subsequent bone gain were studied by the long-term posttransplant follow-up of 360 consecutive adult patients with end-stage primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC). Only 20% of patients with advanced PBC or PSC have normal bone mass. Risk factors for low spinal BMD are low body mass index, older age, postmenopausal status, muscle wasting, high alkaline phosphatase and low serum albumin. A high rate of spinal bone loss occurred in the first 4 posttransplant months (annual rate of 16%) especially in those with younger age, PSC, higher pretransplant bone density, no inflammatory bowel disease, shorter duration of liver disease, current smoking, and ongoing cholestasis at 4 months. Factors favoring spinal bone gain from 4 to 24 months after transplantation were lower baseline and/or 4-month bone density, premenopausal status, lower cumulative glucocorticoids, no ongoing cholestasis, and higher levels of vitamin D and parathyroid hormone. Bone mass therefore improves most in patients with lowest pretransplant BMD who undergo successful transplantation with normal hepatic function and improved gonadal and nutritional status. Patients transplanted most recently have improved bone mass before OLT, and although bone loss still occurs early after OLT, these patients also have a greater recovery in BMD over the years following OLT.

摘要

肝移植(OLT)后发生骨折是由于术前就存在的低骨矿物质密度(BMD)和移植后早期骨质流失共同作用的结果,而其风险因素尚不明确。通过对360例连续性成年终末期原发性胆汁性肝硬化(PBC)和原发性硬化性胆管炎(PSC)患者进行长期移植后随访,研究了肝性骨质减少和骨质疏松、移植后骨质流失以及随后骨质增加的患病率和预测因素。只有20%的晚期PBC或PSC患者骨量正常。低脊柱BMD的风险因素包括低体重指数、年龄较大、绝经后状态、肌肉萎缩、高碱性磷酸酶和低血清白蛋白。移植后的前4个月脊柱骨流失率较高(年流失率为16%),尤其是年龄较小、患有PSC、移植前骨密度较高、无炎症性肠病、肝病病程较短、当前吸烟且在4个月时仍有胆汁淤积的患者。有利于移植后4至24个月脊柱骨质增加的因素包括较低的基线和/或4个月时的骨密度、绝经前状态、较低的累积糖皮质激素用量、无持续性胆汁淤积以及较高水平的维生素D和甲状旁腺激素。因此,对于移植前BMD最低且移植成功、肝功能正常、性腺和营养状况改善的患者,骨量改善最为明显。最近接受移植的患者在OLT前骨量有所改善,尽管OLT后早期仍会发生骨质流失,但这些患者在OLT后的几年中BMD也有更大程度的恢复。

相似文献

1
Bone mineral density before and after OLT: long-term follow-up and predictive factors.肝移植前后的骨矿物质密度:长期随访及预测因素
Liver Transpl. 2006 Sep;12(9):1390-402. doi: 10.1002/lt.20874.
2
Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors.原位肝移植前后的骨折与缺血性坏死:长期随访及预测因素
Hepatology. 2007 Oct;46(4):1198-207. doi: 10.1002/hep.21805.
3
Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis.胆汁淤积的严重程度和晚期组织学分期而非绝经状态是原发性胆汁性肝硬化骨质疏松的主要危险因素。
J Hepatol. 2005 Apr;42(4):573-7. doi: 10.1016/j.jhep.2004.11.035. Epub 2005 Jan 13.
4
Assessment of serial changes of bone mineral density at lumbar spine and femoral neck before and after liver transplantation.肝移植前后腰椎和股骨颈骨密度的系列变化评估。
Chin Med J (Engl). 1999 Apr;112(4):379-81.
5
Elevation of intact parathyroid hormone level is a risk factor for low bone mineral density in pretransplant patients with liver diseases.在患有肝脏疾病的移植前患者中,完整甲状旁腺激素水平升高是骨矿物质密度低的一个风险因素。
Transplant Proc. 2007 Dec;39(10):3182-5. doi: 10.1016/j.transproceed.2007.06.093.
6
Prevention of early loss of bone mineral density after liver transplantation by prostaglandin E1.
Transplant Proc. 2007 Mar;39(2):540-3. doi: 10.1016/j.transproceed.2006.12.016.
7
Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study.原发性胆汁性肝硬化并非接受常规钙和维生素D补充治疗的女性骨质流失的额外危险因素:一项对照纵向研究。
J Clin Gastroenterol. 2008 Mar;42(3):306-11. doi: 10.1097/01.mcg.0000248017.31386.39.
8
Risk factors for changes in bone mineral density and the effect of antiosteoporosis management after renal transplantation.肾移植后骨矿物质密度变化的危险因素及抗骨质疏松治疗的效果
Transplant Proc. 2006 Sep;38(7):2074-6. doi: 10.1016/j.transproceed.2006.06.106.
9
Bone histomorphometric changes after liver transplantation for chronic cholestatic liver disease.
J Bone Miner Res. 2003 Dec;18(12):2190-9. doi: 10.1359/jbmr.2003.18.12.2190.
10
Risk factors for osteoporosis in young renal transplant recipients.
Transplant Proc. 2005 Sep;37(7):3116-8. doi: 10.1016/j.transproceed.2005.07.019.

引用本文的文献

1
Oral Health Status of Children With a History of Liver Transplantation.有肝移植病史儿童的口腔健康状况
Pediatr Transplant. 2025 Aug;29(5):e70125. doi: 10.1111/petr.70125.
2
Side Effects of Immunosuppressant Drugs After Liver Transplant.肝移植后免疫抑制药物的副作用
Pharmaceuticals (Basel). 2025 Feb 27;18(3):342. doi: 10.3390/ph18030342.
3
Five-year evaluation of bone health in liver transplant patients: developing a risk score for predicting bone fragility progression beyond the first year.肝移植患者骨健康的五年评估:制定预测第一年之后骨脆性进展的风险评分
Front Endocrinol (Lausanne). 2025 Feb 20;16:1467825. doi: 10.3389/fendo.2025.1467825. eCollection 2025.
4
Bone Loss after Solid Organ Transplantation: A Review of Organ-Specific Considerations.实体器官移植后的骨质流失:器官特异性考虑因素的综述。
Endocrinol Metab (Seoul). 2024 Apr;39(2):267-282. doi: 10.3803/EnM.2024.1939. Epub 2024 Apr 25.
5
Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation.亚太肝病学会肝脏移植临床实践指南。
Hepatol Int. 2024 Apr;18(2):299-383. doi: 10.1007/s12072-023-10629-3. Epub 2024 Feb 28.
6
Osteoporosis and Fragility Fractures in Patients with Liver Cirrhosis: Usefulness of FRAX as a Screening Tool.肝硬化患者的骨质疏松症和脆性骨折:FRAX作为筛查工具的效用
J Clin Med. 2023 Dec 29;13(1):188. doi: 10.3390/jcm13010188.
7
Post-Transplant Management and Complications of Autoimmune Hepatitis, Primary Biliary Cholangitis, and Primary Sclerosing Cholangitis including Disease Recurrence.移植后管理及自身免疫性肝炎、原发性胆汁性胆管炎和原发性硬化性胆管炎的并发症,包括疾病复发。
Clin Liver Dis. 2024 Feb;28(1):193-207. doi: 10.1016/j.cld.2023.07.009. Epub 2023 Aug 26.
8
Prevalence and risk factors of osteoporosis detected by dual-energy X-ray absorptiometry among Chinese patients with primary biliary cholangitis.原发性胆汁性胆管炎患者双能 X 射线吸收法检测骨质疏松症的患病率和危险因素。
World J Gastroenterol. 2023 Aug 7;29(29):4580-4592. doi: 10.3748/wjg.v29.i29.4580.
9
Osteoporosis Assessment among Adults with Liver Cirrhosis.肝硬化成人的骨质疏松症评估
J Clin Med. 2022 Dec 25;12(1):153. doi: 10.3390/jcm12010153.
10
Bone demineralization in a cohort of Egyptian pediatric liver transplant recipients: Single center pilot study.埃及儿科肝移植受者队列中的骨矿物质减少:单中心初步研究。
Medicine (Baltimore). 2022 Nov 11;101(45):e31156. doi: 10.1097/MD.0000000000031156.